0
Letters |

Grip Strength and Subjective Fatigue in Patients With Primary Biliary Cirrhosis

Jennifer Goldblatt, B Med Sci; Oliver F. W. James, MD; David E. J. Jones, MD, PhD
[+] Author Affiliations

Stephen J. Lurie, MD, PhDSenior Editor: IndividualAuthor
Jody W. Zylke, MDContributing Editor: IndividualAuthor

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
JAMA. 2001;285(17):2196-2197. doi:10.1001/jama.285.17.2196
Text Size: A A A
Published online
Figures in this Article

To the Editor: It has been reported that 80% of patients with primary biliary cirrhosis (PBC) experience generalized fatigue.1 2 Although fatigue can significantly affect quality of life, few studies have addressed its etiology in PBC. Some reports suggest that there may be a significant organic component to the fatigue described by patients with PBC,2 perhaps as a result of peripheral muscle dysfunction.3 We sought to examine the relationship between peripheral muscle dysfunction and fatigue in a larger sample of patients with PBC.

METHODS

Peripheral muscle function was measured with a grip strength protocol in 18 female patients with PBC. Eight patients reported severe fatigue as assessed by the fatigue impact score (mean score, 85 of 160 possible points)2 ,4 and 10 reported minimal fatigue (mean score, 7). We also obtained data from 14 healthy female control subjects who were similar in age. Patients unable to complete the grip strength protocol for nonfatigue-related reasons and those with severe PBC were excluded.

Nondominant hand grip strength was assessed with repeat measurements made every 5 seconds for 5 minutes or until grip strength value reached 50% of the starting value. The median percentage decrease in grip strength per repeat measurement was calculated for each subject.

RESULTS

The initial rested grip strength was similar in fatigued and nonfatigued patients with PBC, and control subjects (median, 18.2 kg [range, 11.2-24.4] vs 19.9 kg [12.9-24.2] vs 18.7 kg [8.0-20.3]; Mann-Whitney, P = .27). In control subjects the median decrease in grip strength per 5-second repeat was 0.7% (range, 0.0%-5.8%). A similar rate of decrease was seen in nonfatigued patients (1.1% per repeat [0.5%-3.9%]; P = .46 vs controls). A significantly greater rate of decrease was seen in fatigued patients (4.0% per repeat [2.1%-10.7%]; P<.005 vs nonfatigued patients, P<.005 vs controls). A significant correlation was seen between fatigue severity and rate of decrease in muscle grip strength (r = 0.69, P<.001 in patients; Figure 1). No association was found between muscle fatigability and liver disease severity (data not shown).

Place holder to copy figure label and caption
Figure. Relationship Between Muscle Grip Strength Decrease and Fatigue Severity in Patients With Primary Biliary Cirrhosis
Grahic Jump Location

A significant correlation between fatigue impact score and rate of decrease in muscle grip strength among PBC patients (r = 0.69, P<.001).

COMMENT

Patients with PBC who complained of fatigue showed a markedly accelerated decrease in muscle function on repeat activity compared with both control subjects and nonfatigued patients. Moreover, there was a strong correlation between the rate at which grip strength is lost and the severity of the fatigue experienced by the patient, suggesting that peripheral muscle fatigability may contribute to the symptom complex experienced by some patients. The etiology of this abnormality in repeat muscle function remains unclear and there appears to be no simple relationship with liver disease severity. We could not exclude a volitional component to the decrease in repeat muscle function, although the finding of normal initial grip strength in the fatigued patients would argue against this. Further studies of peripheral muscle and neuromuscular junction function in PBC-related fatigue are warranted. If a significant peripheral motor system contribution to fatigue in PBC is confirmed, this may suggest new modalities of treatment for this troubling symptom.

REFERENCES

Cauch-Dudek  K, Abbey  S, Stewart  DE, Heathcote  EJ. Fatigue in primary biliary cirrhosis. Gut. 1998;43:705-710.
Prince  MI, James  OFW, Holland  NP, Jones  DEJ. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol. 2000;32:368-373.
Varga  J, Heiman-Patterson  T, Munoz  S, Love  LA. Myopathy with mitochondrial alterations in patients with primary biliary cirrhosis and anti-mitochondrial antibodies. Arthritis Rheum. 1993;36:1468-1475.
Huet  PM, Deslauriers  J, Tran  A, Fancher  C, Charbonneau  J. Impact of fatigue on the quality of life in patients with primary biliary cirrhosis. Am J Gastroenterol. 2000;95:760-767.

First Page Preview

First page PDF preview

Figures

Place holder to copy figure label and caption
Figure. Relationship Between Muscle Grip Strength Decrease and Fatigue Severity in Patients With Primary Biliary Cirrhosis
Grahic Jump Location

A significant correlation between fatigue impact score and rate of decrease in muscle grip strength among PBC patients (r = 0.69, P<.001).

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Cauch-Dudek  K, Abbey  S, Stewart  DE, Heathcote  EJ. Fatigue in primary biliary cirrhosis. Gut. 1998;43:705-710.
Prince  MI, James  OFW, Holland  NP, Jones  DEJ. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol. 2000;32:368-373.
Varga  J, Heiman-Patterson  T, Munoz  S, Love  LA. Myopathy with mitochondrial alterations in patients with primary biliary cirrhosis and anti-mitochondrial antibodies. Arthritis Rheum. 1993;36:1468-1475.
Huet  PM, Deslauriers  J, Tran  A, Fancher  C, Charbonneau  J. Impact of fatigue on the quality of life in patients with primary biliary cirrhosis. Am J Gastroenterol. 2000;95:760-767.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.